首页/数据集/Dataset from A Double-Blind, Randomized, Parallel-Group Study to Compare the Efficacy and Safety of TAK-491 With Ramipril in Subjects With Essential Hypertension

Dataset from A Double-Blind, Randomized, Parallel-Group Study to Compare the Efficacy and Safety of TAK-491 With Ramipril in Subjects With Essential Hypertension

NIAID Data Ecosystem2026-05-02 收录

抗高血压药物临床试验

原发性高血压药物比较

数据链接：

https://doi.org/10.25934/00002500 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to determine the efficacy and safety of azilsartan medoxomil, once daily (QD), compared to ramipril for treating Essential Hypertension.

应用场景：

创建时间：

2025-02-22

血流动力学

抗高血压药物临床试验

Background and Aim Little is known about the tolerability of antihypertensive drugs during hemodialysis treatment. The present study evaluated the use of the angiotensin II receptor blocker (ARB) irbe

NIAID Data Ecosystem40

Dataset from A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Subjects With Essential Hypertension

抗高血压药物临床试验

原发性高血压治疗

The purpose of this study is to determine the safety and efficacy of azilsartan medoxomil, once daily (QD), compared to placebo and olmesartan in participants with essential hypertension.

NIAID Data Ecosystem10

Dataset from A Randomized, Double-blind, Placebo-controlled, Forced-titration, Phase IV Study Comparing Telmisartan 80 mg + Hydrochlorothiazide 25 mg Versus Valsartan 160 mg + Hydrochlorothiazide 25 mg Taken Orally for Eight Weeks in Patients With Stage 1 or Stage 2 Hypertension.

抗高血压药物疗效比较

抗高血压药物临床试验

The primary objective of this study is to compare the effectiveness of telmisartan 80 mg / hydrochlorothiazide 25 mg [Micardis HCT] to valsartan 160 mg / hydrochlorothiazide 25 mg [Diovan HCT] and pla

NIAID Data Ecosystem00

A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low-Medium Risk

抗高血压药物临床试验

原发性高血压治疗

Background Angiotensin II receptor blockers (ARBs) is a well-tolerated class of antihypertensive agents, exhibiting effective antihypertensive and cardiovascular protective function. The objective of

NIAID Data Ecosystem10

Dataset from A Study of CS-3150 to Evaluate Efficacy and Safety in Patients With Primary Aldosteronism

原发性醛固酮增多症

抗高血压药物临床试验

To examine antihypertensive effect and safety of CS-3150 in patients with primary aldosteronism.

NIAID Data Ecosystem00